Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

P1890000

Piperacillin

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

Piperacillin monohydrate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C23H27N5O7S · H2O
Número de CAS:
66258-76-2
Peso molecular:
535.57
Código UNSPSC:
41116107
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

piperacillin

fabricante / nombre comercial

EDQM

aplicaciones

pharmaceutical (small molecule)

formato

neat

temp. de almacenamiento

−20°C

InChI

1S/C23H27N5O7S.H2O/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28;/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34);1H2/t13-,14-,15+,20-;/m1./s1

Clave InChI

NBXPLBPWMYNZTC-IDYPWDAWSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Piperacillin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

1541500

Piperacillin, United States Pharmacopeia (USP) Reference Standard

1541529

Piperacillin Related Compound E, United States Pharmacopeia (USP) Reference Standard

PHR1805

Piperacillin, Pharmaceutical Secondary Standard; Certified Reference Material

BP1027

Piperacillin, British Pharmacopoeia (BP) Reference Standard

Y0002235

Piperacillin for peak identification, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002241

Piperacillin impurity N, CRS, European Pharmacopoeia (EP) Reference Standard

PHR3085

Piperacillin Related Compound E, pharmaceutical secondary standard, certified reference material

Pictogramas

Exclamation mark
GHS07

Palabra de señalización

Warning

Frases de peligro

H317 - H412

Clasificaciones de peligro

Aquatic Chronic 3 - Skin Sens. 1B

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

Lo sentimos, en este momento no disponemos de COAs para este producto en línea.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 8

1 of 8

vibrant-m

C0682800

Cefazolin

vibrant-m

C0690500

Ceftazidime

Linezolid United States Pharmacopeia (USP) Reference Standard

USP

1367561

Linezolid

Ciprofloxacin European Pharmacopoeia (EP) Reference Standard

Y0000198

Ciprofloxacin

Meropenem United States Pharmacopeia (USP) Reference Standard

USP

1392454

Meropenem

Meropenem trihydrate ≥98% (HPLC)

Sigma-Aldrich

M2574

Meropenem trihydrate

Ciprofloxacin ≥98% (HPLC)

Sigma-Aldrich

17850

Ciprofloxacin

Meropenem Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1772

Meropenem

Sangil Jeon et al.
Antimicrobial agents and chemotherapy, 58(7), 3744-3751 (2014-04-23)
Piperacillin in combination with tazobactam, a β-lactamase inhibitor, is a commonly used intravenous antibiotic for the empirical treatment of infection in intensive care patients, including burn patients. The purpose of this study was to develop a population pharmacokinetic (PK) model
Ashley W Sturm et al.
Pharmacotherapy, 34(1), 28-35 (2013-07-19)
To evaluate the steady-state pharmacokinetic and pharmacodynamic parameters of piperacillin in morbidly obese, surgical intensive care patients. Open-label single-center prospective study. Level I trauma center and university-affiliated teaching institution. Nine morbidly obese (body mass index [BMI] 40.0 kg/m² or higher)
Brian D VanScoy et al.
Antimicrobial agents and chemotherapy, 58(10), 6024-6031 (2014-07-30)
It is important to understand the relationship between antibiotic exposure and the selection of drug resistance in the context of therapy exposure. We sought to identify the ceftolozane-tazobactam exposure necessary to prevent the amplification of drug-resistant bacterial subpopulations in a
Raquel Cavalcanti Dantas et al.
Journal of medical microbiology, 63(Pt 12), 1679-1687 (2014-09-28)
The rates of multidrug-resistant, extensively drug-resistant and pandrug-resistant isolates amongst non-fermenting Gram-negative bacilli, particularly Pseudomonas aeruginosa, have risen worldwide. The clinical consequence of resistance and the impact of adverse treatment on the outcome of patients with P. aeruginosa bacteraemia remain
Jessica Krezdorn et al.
Journal of medical microbiology, 63(Pt 7), 945-955 (2014-06-15)
The aim of this study was to compare the inhibitory effect of antibiotic combinations in vitro with efficacy in Galleria mellonella larvae in vivo to identify efficacious combinations that target Pseudomonas aeruginosa. P. aeruginosa NCTC 13437, a multidrug-resistant strain resistant
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico